| 5 | 0 | 64 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探讨罪犯血管再灌注后定量血流分数(QFR)、微血管阻力(AMR)与ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)术后远期预后的关系。方法 选取成功接受PCI的STEMI患者387例,于罪犯血管再灌注后基于冠状动脉造影图像计算QFR、AMR。随访2年,记录患者不良心血管事件发生情况,随访期间发生不良心血管事件则为不良预后。采用多因素Logistic回归分析STEMI患者PCI术后远期不良预后的影响因素,受试者工作特征(ROC)曲线和决策曲线分析(DCA)评价QFR、AMR对STEMI患者PCI术后远期不良预后的预测效能及临床净获益。结果 随访2年,387例STEMI患者PCI术后共有135例(34.88%)预后不良。与不良预后良好患者比较,预后不良患者年龄、糖尿病比例、Gensini评分、心肌肌钙蛋白I、肌酸激酶同工酶MB水平及AMR更高,冠状动脉病变支数更多,支架长度更长,支架直径更短,QFR更低(P均<0.05)。多因素Logistic回归分析显示,年龄增大、Gensini评分升高、冠状动脉多支病变、AMR升高为STEMI患者PCI术后远期不良预后的独立危险因素,QFR升高为独立保护因素(P均<0.05)。构建QFR与AMR的联合预测模型为Logit(P)=3.209-1.517×QFR+0.317×AMR。QFR联合AMR及二者单独预测STEMI患者PCI术后远期不良预后的ROC曲线下面积(AUC)分别为0.898、0.808、0.835,灵敏度分别为85.19%、72.59%、80.74%,特异度分别为82.54%、70.63%、71.83%,二者联合预测的AUC更高(P均<0.05)。DCA结果显示,在3%~95%阈值概率内,二者联合预测的临床净获益高于QFR、AMR单独预测。结论 罪犯血管再灌注后QFR降低和AMR升高为STEMI患者PCI术后远期不良预后的独立影响因素,二者联合评估对不良预后的预测价值及临床净获益更高。
Abstract:Objective To investigate the relationships of quantitative flow ratio(QFR) and angiography-derived microvascular resistance(AMR) after culprit vessel reperfusion with long-term prognosis in patients with ST-segment elevation myocardial infarction(STEMI) after percutaneous coronary intervention(PCI).Methods A total of 387 patients with STEMI who successfully underwent PCI were enrolled.QFR and AMR were calculated based on coronary angiographic images after culprit vessel reperfusion.All patients were followed up for 2 years.Major adverse cardiovascular events occurring during follow-up were recorded, and patients who experienced major adverse cardiovascular events(MACEs) were classified as having a poor prognosis.Multivariate Logistic regression analysis was performed to identify the factors associated with poor long-term prognosis after PCI in patients with STEMI.Receiver operating characteristic(ROC) curve and decision curve analysis(DCA) were used to evaluate the predictive performance and clinical net benefit of QFR and AMR for poor long-term prognosis after PCI.Results During the 2-year follow-up, 135 of the 387 patients(34.88%) experienced poor prognosis.Compared with patients with good prognosis, those with poor prognosis were older, had a higher proportion of diabetes mellitus, higher Gensini scores, higher levels of cardiac troponin I, creatine kinase-MB, and AMR, more diseased coronary vessels, longer stent length, smaller stent diameter, and lower QFR(all P<0.05).Multivariate Logistic regression analysis showed that older age, higher Gensini score, multivessel coronary artery disease, and increased AMR were independent risk factors for poor long-term prognosis after PCI in patients with STEMI, whereas increased QFR was an independent protective factor(all P<0.05).The areas under the ROC curve(AUCs) for the combined assessment of QFR and AMR, QFR alone, and AMR alone were 0.898, 0.808, and 0.835, respectively, with sensitivities of 85.19%, 72.59%, and 80.74%, and specificities of 82.54%, 70.63%, and 71.83%, respectively.The combined model showed a significantly higher AUC than either QFR or AMR alone(both P<0.05).DCA demonstrated that the combined assessment provided a greater clinical net benefit than either QFR or AMR alone across threshold probabilities ranging from 3% to 95%.Conclusions Decreased QFR and increased AMR after culprit vessel reperfusion are independent factors associated with poor long-term prognosis after PCI in patients with STEMI.The combined assessment of QFR and AMR provides superior predictive performance and greater clinical net benefit for predicting poor long-term prognosis.
[1]国家心血管病中心,中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2024概要[J].中国循环杂志,2025,40(6):521-559.
[2]RAO S V, ODONOGHUE M L, RUEL M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes:a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J]. Circulation, 2025,151(13):771-862.
[3]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经皮冠状动脉介入治疗指南(2025)[J].中华心血管病杂志,2025,53(7):717-745.
[4]THRANE P G, OLESEN K K W, THIM T, et al. Temporal trends in cardiovascular events after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J]. JACC Adv, 2025,4(3):101614.
[5]TROGER F, PAMMINGER M, POSKAITE P, et al. Clinical impact of persistent microvascular obstruction in CMR after reperfused STEMI[J]. Circ Cardiovasc Imaging, 2025,18(6):e017645.
[6]ZHANG Z, DAI Y, XUE P, et al. Prediction of microvascular obstruction from angio-based microvascular resistance and available clinical data in percutaneous coronary intervention:an explainable machine learning model[J]. Sci Rep, 2025,15(1):3045.
[7]张慧,王黎,上官海娟,等.基于心脏磁共振评估的冠状动脉微血管阻塞对急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗术后预后的临床研究[J].中国介入心脏病学杂志,2025,33(6):327-333.
[8]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志,2019,47(10):766-783.
[9]曹干,邓毅凡,何胜虎,等.乳酸脱氢酶与白蛋白比值与急性ST段抬高型心肌梗死急诊经皮冠状动脉介入治疗术后患者预后的相关性研究[J].中国全科医学,2025,28(15):1878-1883,1890.
[10]王凯,李浩亮,汪麟,等.急性ST段抬高型心肌梗死患者急诊PCI后左心室收缩功能障碍与心电图QRS时限的关系[J].山东医药,2024,64(23):82-84.
[11]李一萌,徐东霞,苑日康,等.炎症负荷指数在ST段抬高型心肌梗死患者经皮冠状动脉介入术后临床预后评估中的价值[J].海军军医大学学报,2025,46(10):1278-1289.
[12]KRIVICKASŽ,BARAUSKAS M, JODKA N, et al. Outcomes from quantitative flow ratio-guided complete revascularization and angiography-guided percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction[J]. Med Sci Monit, 2025,31:e948085.
[13]SHA X, WANG W, WANG J, et al. Relationship between cardiometabolic index and post-PCI coronary microvascular dysfunction in acute STEMI patients[J]. J Multidiscip Healthc, 2025,18:5591-5602.
[14]SALINAS-CASANOVA J A, JIMÉNEZ-FRANCO V A, JERJESSANCHEZ C, et al. Diagnostic performance of quantitative flow ratio for the assessment of non-culprit lesions in myocardial infarction(QFR-OUTSMART):systematic review and meta-analysis[J]. Catheter Cardiovasc Interv, 2025,105(2):308-320.
[15]WEN W, CHI Y, LIU M, et al. Assessment of coronary microvascular dysfunction by angiography-based index of microcirculatory resistance:an indirect meta-analysis[J]. Cardiology, 2025,150(4):389-405.
[16]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.ST段抬高型心肌梗死患者急诊PCI微循环保护策略中国专家共识[J].中华心血管病杂志,2022,50(3):221-230.
[17]HOU S, ZHU X, ZHAO Q, et al. Quantitative flow ratio-guided staged percutaneous coronary intervention in patients with STsegment elevation myocardial infarction[J]. Heliyon, 2024,10(20):e39335.
[18]耿亮,周林,王兴旭,等. STEMI患者冠状动脉非罪犯血管狭窄血流动力学模式对远期预后的影响[J].中华心血管病杂志,2025,53(3):260-267.
[19]陈逸敏,李光,谢桂庭,等.急性心肌梗死患者左心室重构与冠状动脉微循环及预后的相关性[J].岭南心血管病杂志,2024,30(2):129-134.
[20]CHEN G, WESTRA J, YANG X, et al. A simple angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction[J]. Int J Cardiol, 2024,409:132199.
[21]安洁,陈心怡,赵国力,等.应用QFR微循环阻力指数评估直接经皮冠状动脉治疗患者远期预后[J].心脏杂志,2025,37(4):402-409.
[22]VACHA J, SPACEK M, KAMINEK M, et al. Comparison of myocardial perfusion study and invasive hemodynamic measurement of the significance of non-infarct-related residual stenoses in ST elevation myocardial infarction patients[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2025,169(4):281-287.
[23]DING S, ZHOU Z, ZOU Z, et al. Two-year outcomes of quantitative flow ratio-based physiology-guided percutaneous coronary intervention in patients with low-risk acute coronary syndrome:a prespecified secondary analysis of FAVOR III China[J]. EClinicalMedicine, 2025,88:103461.
[24]ZHANG Z, DAI Q, ZHANG X, et al. Microcirculatory resistance based on a single angiographic view in ST-segment elevation myocardial infarction patients[J]. BMC Cardiovasc Disord, 2025,25(1):357.
[25]高世毅,韩子晨,曾强,等.冠状动脉微血管功能障碍的评估及其对ST段抬高型急性心肌梗死再灌注治疗的预测价值:基于QFR-AMR研究[J].南方医科大学学报,2025,45(12):2767-2776.
基本信息:
中图分类号:R542.22
引用信息:
[1]刘华影,赵鑫蕊,王彬彬.罪犯血管再灌注后QFR、AMR与ST段抬高型心肌梗死患者PCI术后远期不良预后的关系[J].山东医药,2026,66(07):122-127.
基金信息:
河北省中医药类科研计划项目(2022286)
2026-07-25
2026-07-25